M. Psurski et al. / Tetrahedron Letters 53 (2012) 5845–5847
5847
Table 2
and examined in order to evaluate the possible correlation be-
tween the chemical structure of the obtained isothiocyanates, their
biological activity and their potential as anticancer agents. Addi-
tionally, the inhibitory potency of the synthesized compounds
against human neutrophil elastase and chymotrypsin was mea-
sured using fluorescent substrates. Some of them inhibited these
The antiproliferative activity of the synthesized compounds against several cancer
cell lines in vitro
ITC
IC50
LoVoDX
[lM] SD
LoVo
A549
MCF7
1
2
3
4
5
6
7
8
9
10
10
10
12
70
16
13
13
69
19
7
1
11
10
54
71
17
21
27
68
12
8
1
36
2
29
33
60
79
30
34
33
80
40
20
1
1
2
1
1
2
2
3
2
1
serine proteases with k2/Kinact in the range of 80–870 MÀ1 sÀ1
.
1
1
1
2
1
1
2
1
1
1
2
3
1
1
1
2
1
1
47
68
86
34
17
18
66
59
31
2
2
2
2
1
1
3
2
2
However, due to the presence of two electrophilic centers, the
mechanism of inhibition is not clear and investigations of this issue
are underway.
In summary, a rapid and convenient method for the syntheses
of novel 1-isothiocyano-alkylphosphonate diaryl esters, as building
blocks in organic chemistry and as anticancer agents, has been de-
scribed. Their in vitro antiproliferative activity against cancer cells
is in the range of natural isothiocyanates despite the significant dif-
ferences in their structures. This seems to suggest that depletion of
glutathione is the main mechanism for the antiproliferative poten-
tial of isothiocyanates, when –NCS reactivity with small molecules
(such as GSH, glutathione sulfide) is not influenced by the size and
shape of other regions of molecules (excluding electron-withdraw-
ing effects). Additionally, the obtained compounds possess serine
protease inhibitory activity. In our opinion such compounds are a
good starting point to develop a new class of biologically active
agents as potential drugs or as tools in cancer studies.
method. Nevertheless, only compounds 1-3 and 6 (see Table 1)
were obtained as satisfactorily pure products, and for all the other
compounds the crude purity was 65–80%. However, the impurities
could easily be removed using flash chromatography. It should be
noted that in this method the temperature of the reaction had to be
kept in the range of 0–15 °C in order to maintain the yield and pur-
ity at high levels. Allowing the reaction mixture to warm up during
H2O2 addition led to the formation of several side products, and in
most cases, separation of the target compound was difficult.
In both of the methods described, the base employed was tri-
ethylamine (Et3N); N,N-diisopropylethylamine (DIPEA) can be used
with no detrimental influence on the yield and purity. Considering
the fact that the isothiocyanate moiety readily reacts with a pri-
mary amine under basic conditions resulting in thiourea derivative
formation, the pH of the reaction should be kept below 8 to avoid
such a side reaction, and/or an excess of CS2 should be added in or-
der to ensure full conversion of the amine substrate into the dithio-
carbamate salt. For most of the compounds the best yields and
purities were achieved when 4–6 equiv of DIPEA and 10–15 equiv
of CS2 were used along with 1.5 equiv of HBTU as the desulfuriza-
tion agent; 1.1-1.5 equiv of Et3N, and 10–15 equiv of CS2 when 3–
4 equiv of hydrogen peroxide are used. However, in the case of
compounds 7 and 8, the conversions, regardless of the method
used, decreased significantly. For example, from 57% for 7 and
67% for 8 to 11% and 9%, respectively, when four molar equivalents
of DIPEA were used in the HBTU-based method. The most probable
explanation for this is the instability of the corresponding hydro-
bromides under basic conditions. For the other compounds de-
scribed in this Letter, such decomposition was not observed.
All of the compounds synthesized were tested for their antipro-
liferative activity against breast (MCF7), lung (A549), and both
doxorubicin-sensitive (LoVo) and doxorubicin-resistant (LoVoDX)
colon cancer cell lines. The results are presented in Table 2. For
the most active compounds, (1, 2 and 10) the antiproliferative
effects were comparable to those of the naturally occurring
isothiocyanates.9 Clearly, more compounds need to be synthesized
Acknowledgments
This work was supported by a grant of the National Science
Center, grant no. 2011/01/N/NZ4/03361. J.C. thanks the European
Social Fund for support. The authors thank Prof. Tadeusz Gajda
and Dr Waldemar Goldeman for useful discussions.
Supplementary data
Supplementary data associated with this article can be found, in
037. These data include MOL files and InChiKeys of the most
important compounds described in this article.
References and notes
1. Liu, J. Z.; Song, B. A.; Fan, H. T.; Bhadury, P. S.; Wan, W. T.; Yang, S.; Xu, W.; Wu,
J.; Jin, L. H.; Wei, X.; Hu, D. Y.; Zeng, S. Eur. J. Med. Chem. 2010, 45, 5108.
2. Suhas, R.; Chandrashekar, S.; Gowda, D. C. Eur. J. Med. Chem. 2012, 48, 179.
3. Fahey, J. W.; Zalcmann, A. T.; Talalay, P. Phytochem. 2001, 56, 5.
4. Zhang, Y. Carcinogenesis 2012, 33, 2.
5. Zhang, Y. Carcinogenesis 2000, 21, 1175.
6. Soroka, M.; Goldeman, W. Polish Patent PL 196222, 2007; Chem. Abstr. 2008,
149, 556785.
7. Boas, U.; Gertz, H.; Christensen, J. B.; Heegaard, P. M. H. Tetrahedron Lett. 2004,
45, 269.
8. Tajima, H.; Li, G. Synlett 1997, 7, 773.
9. Psurski, M.; Blazewska, K.; Gajda, A.; Gajda, T.; Wietrzyk, J.; Oleksyszyn, J. Bioorg.
Med. Chem. Lett. 2011, 21, 4572.